Skip to main content

EDITORIAL article

Front. Med.
Sec. Pathology
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1551629
This article is part of the Research Topic Tumor Markers of Respiratory Tumors : from Bench to Bedside View all 5 articles

Editorial: Tumor Markers of Respiratory Tumors : from Bench to Bedside

Provisionally accepted
Weiguo Huang Weiguo Huang 1*Chengsheng Yang Chengsheng Yang 2J. Luis Espinoza J. Luis Espinoza 3Lin Wu Lin Wu 4*Jianpin Wen Jianpin Wen 5
  • 1 Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin, Guangxi Zhuang Region, China
  • 2 Guilin Medical University, Guilin, Guangxi Zhuang Region, China
  • 3 School of Health Sciences, College of Medical Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan
  • 4 Hunan Cancer Hospital, Xiangya School of Medicine, Central South University, Changsha, Hunan Province, China
  • 5 Hunan Medical College General Hospital, huaihua, China

The final, formatted version of the article will be published soon.

    TNM staging.the research found that Age, T-stage, radiation, chemotherapy, and brain metastases can affect the OS in NPC with lung metastasis.the nomogram model have better clinical net benefits than TNM staging. Xiao et al successfully established a nomogram model of NPC lung metastasis, which can be used as a supplement to TNM staging and provide reference for clinicians.We still need to search for more sensitive and diagnostic new biomarkers, and at the same time, we need to search for new methods, technologies, and means for early diagnosis and prognosis judgment of respiratory malignancies in clinical big data. As shown in the research of this topic, Tumor Markers of Respiratory Tumors : from Bench to Bedside. The early diagnosis and prognosis assessment of malignant tumors in the respiratory system are of great significance.

    Keywords: tumor markers, lung cancer, nasopharyngeal cancer, Cancer Risk Factors, Prognostic assessment

    Received: 26 Dec 2024; Accepted: 03 Jan 2025.

    Copyright: © 2025 Huang, Yang, Espinoza, Wu and Wen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Weiguo Huang, Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin, Guangxi Zhuang Region, China
    Lin Wu, Hunan Cancer Hospital, Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan Province, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.